Oslo - Delayed Quote NOK

Circio Holding ASA (CRNA.OL)

Compare
0.7080 -0.0240 (-3.28%)
At close: December 20 at 4:19:43 PM GMT+1
Currency in NOK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
123.0000
123.0000
10,002.0000
--
624.0000
Operating Expense
100,626.0000
100,626.0000
503,593.0000
95,601.0000
104,524.0000
Operating Income
-100,503.0000
-100,503.0000
-493,591.0000
-95,601.0000
-103,900.0000
Net Non Operating Interest Income Expense
-11,116.0000
-11,116.0000
-4,561.0000
-1,766.0000
-3,800.0000
Pretax Income
-110,736.0000
-110,736.0000
-495,328.0000
-98,023.0000
-108,403.0000
Tax Provision
--
--
-62,430.0000
-52.0000
-277.0000
Net Income Common Stockholders
-110,736.0000
-110,736.0000
-432,898.0000
-97,971.0000
-108,126.0000
Diluted NI Available to Com Stockholders
-110,736.0000
-110,736.0000
-432,898.0000
-97,971.0000
-108,126.0000
Basic EPS
-16.33
-16.33
-2.30
-33.00
-42.00
Diluted EPS
-16.33
-16.33
-2.30
-33.00
-42.00
Basic Average Shares
6,783.0000
6,783.0000
188,432.0000
2,969.1990
2,570.1990
Diluted Average Shares
6,783.0000
6,783.0000
188,432.0000
2,969.1990
2,570.1990
Total Operating Income as Reported
-100,503.0000
-100,503.0000
-493,591.0000
-95,601.0000
-103,901.0000
Total Expenses
100,626.0000
100,626.0000
503,593.0000
95,601.0000
104,524.0000
Net Income from Continuing & Discontinued Operation
-110,736.0000
-110,736.0000
-432,898.0000
-97,971.0000
-108,126.0000
Normalized Income
-110,736.0000
-110,736.0000
-432,898.0000
-97,971.0000
-108,126.0000
Interest Income
658.0000
658.0000
536.0000
270.0000
596.0000
Interest Expense
3,557.0000
3,557.0000
4,994.0000
2,036.0000
4,353.0000
Net Interest Income
-11,116.0000
-11,116.0000
-4,561.0000
-1,766.0000
-3,800.0000
EBIT
-107,179.0000
-107,179.0000
-490,334.0000
-95,987.0000
-104,050.0000
EBITDA
-105,406.0000
-105,406.0000
-97,661.0000
-94,678.0000
-100,315.0000
Reconciled Depreciation
1,773.0000
1,773.0000
392,673.0000
1,309.0000
3,735.0000
Net Income from Continuing Operation Net Minority Interest
-110,736.0000
-110,736.0000
-432,898.0000
-97,971.0000
-108,126.0000
Normalized EBITDA
-105,406.0000
-105,406.0000
-97,661.0000
-94,678.0000
-100,315.0000
Tax Rate for Calcs
--
--
0.0001
0.0000
0.0000
12/31/2020 - 7/8/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PCIB.OL PCI Biotech Holding ASA
1.3200
-7.04%
 
QUIA.ST Quia Pharma AB (publ)
0.0172
+3.61%
 
DIABIO.ST Diagonal Bio AB (publ)
0.0258
+5.31%
 
ZICC.ST Ziccum AB (publ)
0.3830
-6.36%
 
MODTX.ST Modus Therapeutics Holding AB (publ)
1.9000
-4.76%
 
ABERA.ST Abera Bioscience AB
4.1500
+3.75%
 
ALTE.ST Alteco Medical AB
0.2280
+15.15%
 
LIDDS.ST LIDDS AB (publ)
0.1045
-0.95%
 
BGBIO.OL BerGenBio ASA
8.35
-3.61%
 
NANECH.ST NanoEcho AB
0.1580
+21.54%